Results 41 to 50 of about 6,474 (210)
Modern Psychoactive Substances and Their Detection in Biomedical Samples
Scientific and technological advancement of the mid- and late twentieth century led to the creation of a large number of new psychoactive substances (NPS), diverse in composition and spectrum of action.
A. M. Grigoryev, V. N. Fateenkov
doaj +1 more source
Correlation between blood and oral fluid psychoactive drug concentrations and cognitive impairment in driving under the influence of drugs [PDF]
The effects of drugs on driving performance should be checked with drug concentration in the brain and at the same time with the evaluation of both the behavioural and neurophysiological effects. The best accessible indicator of this information is the
Busardò, Francesco Paolo +6 more
core +1 more source
Challenges Posed by Novel Psychoactive Substances – Middle East Perspective
New psychoactive substances (NPS) are defined as substances of abuse, either in a pure form or a preparation, that are not controlled by the 1961 Single Convention on Narcotic Drugs or the 1971 Convention on Psychotropic Substances, but which may pose a ...
Maciej J. Bogusz
doaj +1 more source
Prevalence of Licit and Illicit Drugs Use during Pregnancy in Mexican Women
For the first time, the present study employed hair testing to investigate the prevalence of classical drugs of abuse and new psychoactive substances use during gestation in a cohort of 300 Mexican pregnant women.
Larissa-María Gómez-Ruiz +9 more
doaj +1 more source
New psychoactive substances (NPS) escape routine drug testing: a case report of phenibut [PDF]
Phenibut (β − phenyl − γ−aminobutyric acid) is licensed for use as a medicine in countries outside of the European Union (EU), but has also been sold as a “food supplement” from online shops to the general public in the EU. We present a case of phenibut use in a 25-year-old female undergoing alcohol and drug addiction treatment.
Torben Breindahl +2 more
openaire +2 more sources
Introduction: Novel psychoactive substances (NPS) continue to pose challenges to law enforcement authorities, public health officers and policymakers as suppliers continuously adapt to control measures, thus remaining highly dynamic in introducing ...
Jessica Neicun +2 more
doaj +1 more source
Background: Synthetic cathinones currently represent one of the most predominant (sub)-classes of new psychoactive substance (NPS) in illicit drug markets.
Abdulaziz A. Aldubayyan +3 more
doaj +1 more source
Background and Aims: New psychoactive substances (NPS) pose challenges not only due to their harms to users but also because they are difficult to monitor with traditional epidemiologic methods.
Gabriel Gatica-Bahamonde +8 more
doaj +1 more source
An index of fatal toxicity for new psychoactive substances [PDF]
The final, definitive version of this paper has been published in Journal of Psychopharmacology, February 2018, published by SAGE Publishing, All rights reserved.An index of fatal toxicity for new psychoactive substances has been developed based solely ...
Corkery, John, King, L.A.
core +2 more sources
Closing Evidence Gaps on the Prevalence and Harms of New Psychoactive Substances in Scotland [PDF]
This paper considers the state of knowledge on New Psychoactive Substances (NPS) in Scotland, with a focus on prevalence and harms and puts forward proposals which may assist in closing existing evidence ...
Gillies, Allan
core

